Share of newly FDA approved personalized medicines in 2023, by indicated treatment

Published by
Matej Mikulic,
Apr 17, 2024
This statistic displays the percentage of newly FDA approved personalized medicines in 2023, by indicated treatment. In that year, over 60 percent of all newly approved personalized medicines were drugs and therapies for rare diseases.

Distribution of newly FDA approved personalized medicines in 2023, by indicated treatment

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

2024

Region

United States

Survey time period

2023

Number of respondents

12 new molecular entities and five newly approved

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Personalized medicine "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Personalized medicine

Premises

7

Biomarkers

6

PM key data

5

Views on PM

6

Outlook

4

Further Content: You might find this interesting as well

Topics

Personalized medicineGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCancer in the U.S.
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu